Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial-Reference-Cited by-同舟云学术

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Published:2020-04 Issue:4 Volume:21 Page:571-580
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Qin Shukui,Ren Zhenggang,Meng Zhiqiang,Chen Zhendong,Chai Xiaoli,Xiong Jianping,Bai Yuxian,Yang Lin,Zhu Hong,Fang Weijia,Lin Xiaoyan,Chen Xiaoming,Li Enxiao,Wang Linna,Chen Chunxia,Zou Jianjun

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries;Zeng;Lancet Glob Health,2018

4. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 423 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimode Ultrasound Model for Predicting the Early Treatment Response of Anti-VEGF Agents Plus Anti-PD-1 Antibody in Patients with Unresectable Hepatocellular Carcinoma;Ultrasound in Medicine & Biology;2024-09

2. Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8⁺T cell infiltration;Journal for ImmunoTherapy of Cancer;2024-09

3. Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial;Med;2024-09

4. Camrelizumab Combined with Transcatheter Arterial Chemoembolization for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2024-09

5. Phase I–IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies;International Journal of Molecular Sciences;2024-08-27